Kojo Seys John Elenitoba-Johnson, MD

Highlights

1
Journal of clinical pathology · 2024
KSKojo Seys John Elenitoba-Johnson
PMID: 37156613PMCID: PMC11867640DOISenior author6 citations

189

3 grants

PI
TYK2 Fusions in Lymphoma
NCI · 2025–2029 · via NIH RePORTER
R01CA297080-01A1
PI
Genomic biomarkers of splenic lymphoma
NCI · 2020–2026 · via NIH RePORTER
R01CA255655-06
PI
Epiproteomics of Sezary Syndrome
NCI · 2020–2026 · via NIH RePORTER
R01CA251764-06

Completed grants (6)

PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
NCI · 2019–2024 · via NIH RePORTER
R01CA231021-06
PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
NCI · 2009–2014 · via NIH RePORTER
R01CA136905-05
PI
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
NIDCR · 2008–2012 · via NIH RePORTER
R01DE019249-04
PI
Quantitative proteomic analysis of lymphoma transformation
NCI · 2006–2009 · via NIH RePORTER
R33CA112061-04
PI
Quantitative RT-PCR: Prediction Lymphoma Transformation
NCI · 2005–2006 · via NIH RePORTER
R42CA113212-01
PI
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMAS
NCI · 2000–2002 · via NIH RePORTER
R21CA083984-02